目前关于lncRNA和E2F1之间的交叉通话的概念:揭示癌症治疗方法
Peng Huang1,2, Feng Wen1,3, Qiu Li1,2
1Division of Abdominal Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Frontiers in pharmacology
|August 9, 2024
概括
长非编码RNAs (lncRNAs) 通过与E2F1通路相互作用来调节癌症. 针对这些lncRNA/E2F1相互作用提供了有前途的治疗策略,以改善癌症患者的治疗结果.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
背景情况:
- 长非编码RNAs (lncRNAs) 是生物过程中的关键调节者,包括癌症的开始和进展.
- 失调的lncRNAs作为竞争性内源RNAs (ceRNAs) 或结合RNA结合蛋白,形成复杂的调节网络.
- 转录因子E2F1对于恶性行为至关重要,如细胞周期进展和转移.
研究的目的:
- 审查癌症中lncRNAs和E2F1之间的复杂基因调节程序.
- 详细阐述在癌症进展中涉及lncRNAs和E2F1的机制网络.
- 突出 lncRNA/E2F1轴在癌症治疗中的治疗潜力.
主要方法:
- 在癌症中调查lncRNA和E2F1相互作用的研究的文献综述.
- 通过lncRNAs和E2F1.1控制癌症进展的机制网络的分析.
- 综合目前的证据,局限性和未来的方向.
主要成果:
- 在癌症中,lncRNAs在调节E2F1通路方面发挥着关键作用.
- 特定的lncRNA/E2F1轴涉及瘤开始,进展,转移和治疗反应.
- 这些相互作用形成了复杂的调节网络,对癌症发展至关重要.
结论:
- lncRNA/E2F1轴代表了新型癌症治疗的有希望的目标.
- 了解这些复杂的网络可以促进临床翻译和改善患者的预后.
- 需要进一步的研究来完全破译和利用这些机制,以获得治疗效益.
相关概念视频
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Non-LTR Retrotransposons
11.4K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.4K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K


